2025 / 03

Next Paper
DOI: 10.24075/brsmu.2025.029
Copyright: © 2025 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Newborn screening in North Ossetia in 2023–2024

Zinchenko RA1, Tebieva IS2,3, Zakharova EYu1, Shchagina OA1, Lotnik EE1, Gabisova YuV3, Khokhova AV2,3, Bakin NV1, Marakhonov AV1
About authors

1 Research Centre for Medical Genetics, Moscow, Russia

2 North-Ossetian State Medical Academy, Vladikavkaz, Russia

3 Republican Children’s Clinical Hospital, Vladikavkaz, Russia

Correspondence should be addressed: Rena A. Zinchenko
Moskvorechie, 1, 115522, Moscow, Russia; ur.liam@oknehcnizaner

About paper

Funding: the study was funded by the federal and regional budgets in terms of implementing expanded newborn screening and supported as part of the State Assignment of the Research Centre for Medical Genetics and the Ministry of Health of the Republic of North Ossetia–Alania.

Author contribution: Tebieva IS, Gabisova YuV, Khokhova AV — data acquisition, establishing the diagnosis; Zinchenko RA, Tebieva IS — study planning, manuscript writing; Zakharova EYu, Shchagina OA, Lotnik EE, Bakin NV, Marakhonov AV — molecular genetic testing; Zinchenko RA, Tebieva IS, Zakharova EYu — manuscript editing.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Research Centre for Medical Genetics (protocol No. 7 dated 20 December 2017), it was compliant with the standards of Good Clinical Practice and evidence-based medicine. All patients submitted informed consent to participate in the study.

Received: 2025-04-22 Accepted: 2025-05-19 Published online: 2025-05-30
|
  1. Voronin SV, Kucev SI. Neonatal'nyj skrining na nasledstvennye zabolevanija v Rossii: vchera, segodnja, zavtra. Neonatologija: novosti, mnenija, obuchenie. 2022; 10 (4): 34–39. DOI: https://doi.org/10.33029/2308-2402-2022-10-4-34-39. Russian.
  2. Voronin SV, Zaharova EYu, Bajdakova GV, Marahonov AV, Shhagina OP, Ryzhkova NV, i dr. Rasshirennyj neonatal'nyj skrining na nasledstvennye zabolevanija v Rossii: pervye itogi i perspektivy. Pediatrija im. G. N. Speranskogo. 2024; 103 (1): 16–29. DOI: 10.24110/0031-403X-2024-103-1-16-29. Russian.
  3. Associacija medicinskih genetikov. Sojuz pediatrov Rossii. Associacija zdorov'ja detej. Klinicheskie rekomendacii. Klassicheskaja fenilketonurija i drugie vidy giperfenilalaninemii. 2025, 112 c. Russian.
  4. Kucev SI, redaktor. Nacional'noe rukovodstvo. M.: GOJeTAR-Medicina, 2023; 360 s. DOI:10.33029/9704-7737-3-NEO-2023-1-360. Russian.
  5. Tebieva IS, Mishakova PV, Gabisova YV, Khokhova AV, Kaloeva TG, Marakhonov AV, et al. Genetic Landscape and Clinical Features of Hyperphenylalaninemia in North Ossetia-Alania: high frequency of P281L and P211T genetic variants in the PAH gene. International Journal of Molecular Sciences. 2024; 25 (4): 4598. Available from: https://doi.org/10.3390/ijms25094598.
  6. Mihajlova SV, Zaharova EJu, Petruhin AS. Nejrometabolicheskie zabolevanija u detej i podrostkov: diagnostika i podhody k lecheniju. M.: Litterra, 2024; 400 s. ISBN 978-5-4235-0417-5, DOI: 10.33029/4235-0417-5-NEI-2024-1-400. Russian.
  7. Megarbane A, Bizzari S, Deepthi A, Sabbagh S, Mansour H, Chouery E, et al. A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort. J Neuromuscul Dis. 2022; 9 (1): 193–210. DOI: 10.3233/JND-210652.
  8. Associacija medicinskih genetikov. Rossijskaja associacija pediatricheskih centrov. Vserossijskoe obshhestvo nevrologov. Associacija professional'nyh uchastnikov hospisnoj pomoshhi. Federal'nye klinicheskie rekomendacii. Proksimal'naja spinal'naja myshechnaja atrofija 5q. 2023. Russian.
  9. Tebieva IS. Jeffektivnost' neonatal'nogo skrininga v vyjavlenii kliniko-genealogicheskih osobennostej nasledstvennyh boleznej i optimizacija sistemy ih diagnostiki i lechenija (dissertacija). Moskva, 2012. Russian.
  10. Tebieva IS, Gabisova YuV, Zinchenko RA. Rezul'taty 15-letnego neonatal'nogo skrininga v Respublike Severnaja OsetijaAlanija. Medicinskaja genetika. 2023; 22 (2): 40–47. Russian.
  11. Yuan Tian, Xinyun Zhu, Shubo Lv, Chenlu Jia, Linlin Zhang, Min Ni, et al. Analysis of gene mutations of medium-chain acyl-coenzyme a dehydrogenase deficiency (MCADD) by nextgeneration sequencing in Henan, China. Clinica Chimica Acta. 2022; 536: 155–61. Available from: https://doi.org/10.1016/j.cca.2022.09.008.
  12. Pourfarzam M, Zadhoush F. Newborn Screening for inherited metabolic disorders; news and views. J Res Med Sci. 2013; 18 (9): 801–8;
  13. Nikolaeva EA, Mamedov IS. Diagnostika i lechenie nasledstvennyh defektov obmena zhirnyh kislot u detej. Rossijskij vestnir perinatologii i pediatrii. 2009; 2: 51–65. Russian.
  14. Surkov AN, Gundobina OS, Poljakova SI, Zhurkova NV, Zaharova EYu, i dr. Sluchaj nedostatochnosti acil-KoA-degidrogenazy zhirnyh kislot so srednej dlinoj cepi u rebenka dvuh let. Pediatrija. 2011; 5 (64): 14–18. Russian.
  15. Wilcken B, Haas M, Joy P, Wiley V, Chaplin M, Black С, et al. Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study. Lancet. 2007; 369 (9555): 37-42. DOI: 10.1016/S0140-6736(07)60029-4. PMID: 17208640.
  16. Li YY, Xu J, Sun XC, Li HY, Mu K. Newborn screening and genetic variation of medium chain acyl-CoA dehydrogenase deficiency in the Chinese population. J Pediatr Endocrinol Metab. 2022; 35 (10): 1264–71. DOI: 10.1515/jpem-2022-0394. PMID: 36068006.
  17. Smith EH, Thomas C, McHugh D, Gavrilov D, Raymond K, Rinaldo P, et al. Allelic diversity in MCAD deficiency: the biochemical classification of 54 variants identified during 5 years of ACADM sequencing. Mol Genet Metab. 2010; 100 (3): 241–50. DOI: 10.1016/j.ymgme.2010.04.001. Epub 2010 Apr 8. PMID: 20434380.
  18. Waisbren SE. Newborn screening for metabolic disorders. JAMA. 2006; 296 (8): 993–5. DOI: 10.1001/jama.296.8.993. PMID: 16926360.
  19. Nikolaeva EA, Semjachkina AN. Sovremennye vozmozhnosti lechenija nasledstvennyh zabolevanij u detej. Roscijskij vestnik perinatologii i pediatrii 2018; 63 (4): 6–14. DOI: 10.21508/1027-4065-2018-63-4-6-14ju. Russian.
  20. Andresen BS, Dobrowolski SF, O'Reilly L, Muenzer J, McCandless SE, Frazier DM, et ak. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet. 2001; 68 (6): 1408-18. DOI: 10.1086/320602. Epub 2001 May 8. PMID: 11349232; PMCID: PMC1226127.
  21. Andresen BS, Lund AM, Hougaard DM, Christensen E, Gahrn B, et al. MCAD deficiency in Denmark. Molecular Genetics and Metabolism. 2012; 106 (2): 175–88. Available from: https://doi.org/10.1016/j.ymgme.2012.03.018.